Anti-TNFα therapy transiently improves high density lipoprotein cholesterol levels and microvascular endothelial function in patients with rheumatoid arthritis: a Pilot Study

<p>Abstract</p> <p>Background</p> <p>Rheumatoid arthritis (RA) is associated with increased morbidity and mortality from cardiovascular disease (CVD). This can be only partially attributed to traditional CVD risk factors such as dyslipidaemia and their downstream effect...

Full description

Bibliographic Details
Main Authors: Sandoo Aamer, van Zanten Jet J C S, Toms Tracey E, Carroll Douglas, Kitas George D
Format: Article
Language:English
Published: BMC 2012-07-01
Series:BMC Musculoskeletal Disorders
Subjects:
Online Access:http://www.biomedcentral.com/1471-2474/13/127
id doaj-a85c7c965ca04f8f84690b992192f843
record_format Article
spelling doaj-a85c7c965ca04f8f84690b992192f8432020-11-24T23:51:18ZengBMCBMC Musculoskeletal Disorders1471-24742012-07-0113112710.1186/1471-2474-13-127Anti-TNFα therapy transiently improves high density lipoprotein cholesterol levels and microvascular endothelial function in patients with rheumatoid arthritis: a Pilot StudySandoo Aamervan Zanten Jet J C SToms Tracey ECarroll DouglasKitas George D<p>Abstract</p> <p>Background</p> <p>Rheumatoid arthritis (RA) is associated with increased morbidity and mortality from cardiovascular disease (CVD). This can be only partially attributed to traditional CVD risk factors such as dyslipidaemia and their downstream effects on endothelial function. The most common lipid abnormality in RA is reduced levels of high-density lipoprotein (HDL) cholesterol, probably due to active inflammation. In this longitudinal study we hypothesised that anti-tumor necrosis factor-α (anti-TNFα) therapy in patients with active RA improves HDL cholesterol, microvascular and macrovascular endothelial function.</p> <p>Methods</p> <p>Twenty-three RA patients starting on anti-TNFα treatment were assessed for HDL cholesterol level, and endothelial-dependent and -independent function of microvessels and macrovessels at baseline, 2-weeks and 3 months of treatment.</p> <p>Results</p> <p>Disease activity (CRP, fibrinogen, DAS28) significantly decreased during the follow-up period. There was an increase in HDL cholesterol levels at 2 weeks (<it>p</it> < 0.05) which was paralleled by a significant increase in microvascular endothelial-dependent function (<it>p</it> < 0.05). However, both parameters returned towards baseline at 12 weeks.</p> <p>Conclusion</p> <p>Anti-TNFα therapy in RA patients appears to be accompanied by transient but significant improvements in HDL cholesterol levels, which coexists with an improvement in microvascular endothelial-dependent function.</p> http://www.biomedcentral.com/1471-2474/13/127DyslipidaemiaAnti-TNFαEndothelial functionRheumatoid arthritisCardiovascular disease
collection DOAJ
language English
format Article
sources DOAJ
author Sandoo Aamer
van Zanten Jet J C S
Toms Tracey E
Carroll Douglas
Kitas George D
spellingShingle Sandoo Aamer
van Zanten Jet J C S
Toms Tracey E
Carroll Douglas
Kitas George D
Anti-TNFα therapy transiently improves high density lipoprotein cholesterol levels and microvascular endothelial function in patients with rheumatoid arthritis: a Pilot Study
BMC Musculoskeletal Disorders
Dyslipidaemia
Anti-TNFα
Endothelial function
Rheumatoid arthritis
Cardiovascular disease
author_facet Sandoo Aamer
van Zanten Jet J C S
Toms Tracey E
Carroll Douglas
Kitas George D
author_sort Sandoo Aamer
title Anti-TNFα therapy transiently improves high density lipoprotein cholesterol levels and microvascular endothelial function in patients with rheumatoid arthritis: a Pilot Study
title_short Anti-TNFα therapy transiently improves high density lipoprotein cholesterol levels and microvascular endothelial function in patients with rheumatoid arthritis: a Pilot Study
title_full Anti-TNFα therapy transiently improves high density lipoprotein cholesterol levels and microvascular endothelial function in patients with rheumatoid arthritis: a Pilot Study
title_fullStr Anti-TNFα therapy transiently improves high density lipoprotein cholesterol levels and microvascular endothelial function in patients with rheumatoid arthritis: a Pilot Study
title_full_unstemmed Anti-TNFα therapy transiently improves high density lipoprotein cholesterol levels and microvascular endothelial function in patients with rheumatoid arthritis: a Pilot Study
title_sort anti-tnfα therapy transiently improves high density lipoprotein cholesterol levels and microvascular endothelial function in patients with rheumatoid arthritis: a pilot study
publisher BMC
series BMC Musculoskeletal Disorders
issn 1471-2474
publishDate 2012-07-01
description <p>Abstract</p> <p>Background</p> <p>Rheumatoid arthritis (RA) is associated with increased morbidity and mortality from cardiovascular disease (CVD). This can be only partially attributed to traditional CVD risk factors such as dyslipidaemia and their downstream effects on endothelial function. The most common lipid abnormality in RA is reduced levels of high-density lipoprotein (HDL) cholesterol, probably due to active inflammation. In this longitudinal study we hypothesised that anti-tumor necrosis factor-α (anti-TNFα) therapy in patients with active RA improves HDL cholesterol, microvascular and macrovascular endothelial function.</p> <p>Methods</p> <p>Twenty-three RA patients starting on anti-TNFα treatment were assessed for HDL cholesterol level, and endothelial-dependent and -independent function of microvessels and macrovessels at baseline, 2-weeks and 3 months of treatment.</p> <p>Results</p> <p>Disease activity (CRP, fibrinogen, DAS28) significantly decreased during the follow-up period. There was an increase in HDL cholesterol levels at 2 weeks (<it>p</it> < 0.05) which was paralleled by a significant increase in microvascular endothelial-dependent function (<it>p</it> < 0.05). However, both parameters returned towards baseline at 12 weeks.</p> <p>Conclusion</p> <p>Anti-TNFα therapy in RA patients appears to be accompanied by transient but significant improvements in HDL cholesterol levels, which coexists with an improvement in microvascular endothelial-dependent function.</p>
topic Dyslipidaemia
Anti-TNFα
Endothelial function
Rheumatoid arthritis
Cardiovascular disease
url http://www.biomedcentral.com/1471-2474/13/127
work_keys_str_mv AT sandooaamer antitnfatherapytransientlyimproveshighdensitylipoproteincholesterollevelsandmicrovascularendothelialfunctioninpatientswithrheumatoidarthritisapilotstudy
AT vanzantenjetjcs antitnfatherapytransientlyimproveshighdensitylipoproteincholesterollevelsandmicrovascularendothelialfunctioninpatientswithrheumatoidarthritisapilotstudy
AT tomstraceye antitnfatherapytransientlyimproveshighdensitylipoproteincholesterollevelsandmicrovascularendothelialfunctioninpatientswithrheumatoidarthritisapilotstudy
AT carrolldouglas antitnfatherapytransientlyimproveshighdensitylipoproteincholesterollevelsandmicrovascularendothelialfunctioninpatientswithrheumatoidarthritisapilotstudy
AT kitasgeorged antitnfatherapytransientlyimproveshighdensitylipoproteincholesterollevelsandmicrovascularendothelialfunctioninpatientswithrheumatoidarthritisapilotstudy
_version_ 1725476537181929472